Medicines In Development: Mental Illness 2012
September 1, 2012
A report has been released by the Pharmaceutical Research and Manufacturers of America listing medications in development to treat mental illnesses. The list provides the status of each medication regarding its approval by the U.S. Food and Drug Administration, the manufacturer, and the targeted condition. There are about 200 medications in the development pipeline, with 52 for depression, 37 for schizophrenia, and 26 for anxiety.
Download the Report
. . .
